SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Corzillius, M
Right arrow Articles by Stucki, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corzillius, M
Right arrow Articles by Stucki, G
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Lupus
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Responsiveness and sensitivity to change of SLE disease activity measures

M Corzillius

II. Department of Internal Medicine, Christian-Albrechts-University of Kiel, Chemnitzstr. 33, 24116 Kiel, Germany m.corzillius{at}med2.uni-kiel.de

P Fortin

Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Department of Medicine, McGill University, Montreal, Quebec, Canada

G Stucki

Ludwig Maximilian-University, Department of Physical Medicine, Munich, Germany

The ability of outcome measures to detect change over time is critical for their usefulness in clinical trials. Two concepts are applied in the assessment of evaluative instruments: We endorse the recommendation that a distinction be made between sensitivity and responsiveness. Sensitivity to change refers to the capacity of instruments to measure change statistically. Sensitivity statistics relate the magnitude of observed change to some measure of variablity and are essentially signal-to-noise ratios. Responsiveness addresses the detection of clinically relevant change. The methodology is still evolving but a common approach has been to correlate the observed change in scores with external standards that are believed to indicate clinical relevance (e.g., physician-or patient-based transition scales).

Sensitivity to change and responsiveness of SLE activity indices have been addressed in a small number of studies. These indicate that the most widely used systems (SLEDAI. SLAM, BILAG) are sensitive to change although the available evidence does not allow preference for one instrument over the others. Little research has been done on the responsiveness of these measures.

This article reviews the methodological concepts in measuringclinical change and summarizes reports on sensitivity and responsiveness of lupus activity scores.

Key Words: SLE • diseaseactivity • outcomemeasures • responsiveness

Lupus, Vol. 8, No. 8, 655-659 (1999)
DOI: 10.1191/096120399680411416


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
P. Minnock, J. Kirwan, and B. Bresnihan
Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritis
Rheumatology, December 1, 2009; 48(12): 1533 - 1536.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Barosi, D. Bordessoule, J. Briere, F. Cervantes, J.-L. Demory, B. Dupriez, H. Gisslinger, M. Griesshammer, H. Hasselbalch, R. Kusec, et al.
Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)
Blood, October 15, 2005; 106(8): 2849 - 2853.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
G Ruiz-Irastorza and M A Khamashta
Evaluation of systemic lupus erythematosus activity during pregnancy
Lupus, September 1, 2004; 13(9): 679 - 682.
[Abstract] [PDF]


Home page
LupusHome page
J Schiffenbauer and L S Simon
Randomized controlled trials in systemic lupus erythematosus: what has been done and what do we need to do?
Lupus, May 1, 2004; 13(5): 398 - 405.
[Abstract] [PDF]



Advertisement